Is the price fair?
What NVST's price assumes
Envista Holdings Corporation trades at 65.4× earnings against 40.2× for the median Medical Instruments & Supplies name, more expensive than its own group.
65.4
Trailing P/E · Medical Instruments & Supplies median 40.2 · 1.63× the median: the market pays up for this one
- Price / sales
- 1.53
Price / sales · as of 2026-Q1
- Free cash flow yield
- 5.1%
Free cash flow yield · Medical Instruments & Supplies median 3.7%
- Growth the price implies
- +5.4%
Growth the price implies · The price pays for +5.4% free cash flow growth a year for a decade; the business has delivered +26% a year over the last three.
Details›
- Price / book2026-Q1
- 1.39
- EV / EBIT2026-Q1
- 19.4
- EV / sales2026-Q1
- 1.66
- Healthcare median P/E362 names
- 29.9
- Medical Instruments & Supplies median P/E29 names
- 40.2
- Free cash flow, trailing twelve months
- $220M
- Market capitalisation
- $4.34B
- 3-year revenue growth
- +3.1%
- 3-year free cash flow growth
- +26%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #15 of 19 by Smart Score